^Homoki J, Teller WM, Fazekas AT (April 1976). "A test for heterozygocity of 21-hydroxylase deficiency: preliminary report". Human Genetics. 32 (1): 35–41. doi:10.1007/BF00569974. PMID177352. S2CID20559786.
^Halperin G, Finkelstein M (March 1967). "Biosynthesis of pregnanetriolone and pregnanetetrol in congenital adrenal hyperplasia". Acta Endocrinologica. 54 (3): 439–51. doi:10.1530/acta.0.0540439. PMID6071362.
^Thomas FJ, Steinbeck AW (April 1969). "Quantitative estimation of urinary pregnanetriol, pregnanetriolone, tetrahydro S and delta-5-pregnenetriol in the investigation of adrenocortical function". Acta Endocrinologica. 60 (4): 657–68. doi:10.1530/acta.0.0600657. PMID5819067.
^Zachmann M, Prader A (March 1978). "Unusual heterozygotes of congenital adrenal hyperplasia due to 21-hydroxylase deficiency". Acta Endocrinologica. 87 (3): 557–65. doi:10.1530/acta.0.0870557. PMID580145.
^Kamrath C, Friedrich C, Hartmann MF, Wudy SA (July 2023). "Metabotypes of congenital adrenal hyperplasia in infants determined by gas chromatography-mass spectrometry in spot urine". J Steroid Biochem Mol Biol. 231: 106304. doi:10.1016/j.jsbmb.2023.106304. PMID36990162. S2CID257775623.